Clinical Trial Update: Plasma Orexin A and mRNA Expression Levels of Pre-pro-orexin Gene in Attention-Deficit Hyperactivity Disorder

View source ↗

Summary

A clinical trial update examining plasma orexin A levels and pre-pro-orexin mRNA expression in individuals with Attention-Deficit Hyperactivity Disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Attention Deficit Hyperactivity Disorder (ADHD) | Status: UNKNOWN